Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

NCT02813486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Diphtheria
Whooping Cough

Interventions

BIOLOGICAL: Biological: GC3111 vaccine
BIOLOGICAL: Biological: Boostrix® vaccine

Sponsor

Green Cross Corporation